Therapeutic plasma exchange in Casablanca

被引:6
作者
Tazi, I. [1 ]
Merimi, F. [1 ]
Majd, A. [1 ]
Benchemsi, N. [1 ]
机构
[1] Ctr Reg Transfus Sanguine, Casablanca, Morocco
关键词
therapeutic plasma exchange; Casablanca; treatment; outcome;
D O I
10.1016/j.transci.2008.05.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Therapeutic plasma exchange (TPE) is an extracorporeal blood purification method for the treatment of diseases in which pathological proteins have to be eliminated. In the aim to demonstrate our single center activity, we analyzed our data since 2 years. Methods: Between years 2002 and 200:5, 104 TPE procedures were performed on 42 patients. Median age and male/female ratio were 32 (range, 17-56) and 24/18, respectively. Departments those referred the majority of the TPE were neurology (n = 32), nephrology (n = 5) and intensive care unit (n = 5). The most common indications were: polyradiculoneuropathies (53%), myasthenia gravis (17%) and Guillain-Barre syndrome (12%). Results: The median TPE procedure per patient was 2.3 (range, 1-10). In the majority of patients, vascular access was provided by puncture of two large, durable peripheral antecubital veins. The procedures were performed with the "Haemonetic Ultralight" discontinuous flow cell separator devices. Citrate solution was used as an anticoagulant in all cases. The substitution fluids most often used in our unit are Albumin 20% solution (92 times), Albumin 41% (10 times) and fresh frozen plasma. (twice). Seventy five percent of the patients showed improvement, 7% remained the same and 18% worsened. Thirteen adverse reactions were recorded. Conclusion: The creation of a national registry by the local society is a vital move to improve TPE practice in our country. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 48
页数:4
相关论文
共 25 条
  • [1] ARSLAN O, 1998, 26 NAT HEM C SCI M S, P197
  • [2] BORBERG H, 1980, THERAPEUTIC PLASMA E
  • [3] Therapeutic plasma exchange: An update from the Canadian Apheresis Group
    Clark, WF
    Rock, GA
    Buskard, N
    Shumak, KH
    LeBlond, P
    Anderson, D
    Sutton, DM
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (06) : 453 - 462
  • [4] Isbister JP, 1990, THERAPEUTIC HEMAPHER, P10
  • [5] Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies
    Kincaid, JC
    [J]. THERAPEUTIC APHERESIS, 2002, 6 (01): : 53 - 56
  • [6] Koo A P, 1999, Ther Apher, V3, P4
  • [7] 14 years of therapeutic plasma exchange in France
    Korach, JM
    Petitpas, D
    Poiron, L
    Vincent, N
    Berger, P
    Chillet, P
    [J]. TRANSFUSION AND APHERESIS SCIENCE, 2001, 25 (01) : 73 - 77
  • [8] International forum: France the national survey of plasma exchange and therapeutic cytapheresis in France
    Korach, JM
    Bussel, A
    Gajdos, P
    [J]. TRANSFUSION SCIENCE, 1995, 16 (04): : 363 - 370
  • [9] Role of replacement fluids in the immediate complications of plasma exchange
    Korach, JM
    Berger, P
    Giraud, C
    Le Perff-Desman, C
    Chillet, P
    [J]. INTENSIVE CARE MEDICINE, 1998, 24 (05) : 452 - 458
  • [10] Apheresis technologies and clinical applications: The 2000 International Apheresis Registry
    Malchesky, PS
    Koo, AP
    Rybicki, LA
    [J]. THERAPEUTIC APHERESIS, 2001, 5 (03): : 193 - 203